Original Contribution | Published:

Large and Small Intestine; Inflammatory Bowel Disease

Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome

American Journal of Gastroenterology volume 95, pages 12311238 (2000) | Download Citation




The influence of the gastrointestinal (GI) microflora in patients with irritable bowel syndrome (IBS) has not been clearly elucidated. This study was undertaken to see if patients with IBS have an imbalance in their normal colonic flora, as some bacterial taxa are more prone to gas production than others. We also wanted to study whether the flora could be altered by exogenous supplementation. In a previous study we have characterized the mucosa-associated lactobacilli in healthy individuals and found some strains with good colonizing ability. Upon colonization, they seemed to reduce gas formation.


The study comprised 60 patients with IBS and a normal colonoscopy or barium enema. Patients fulfilling the Rome criteria, without a history of malabsorption, and with normal blood tests underwent a sigmoidoscopy with biopsy. They were randomized into two groups, one receiving 400 ml per day of a rose-hip drink containing 5 × 107 cfu/ml of Lactobacillus plantarum (DSM 9843) and 0.009 g/ml oat flour, and the other group receiving a plain rose-hip drink, comparable in color, texture, and taste. The administration lasted for 4 wk. The patients recorded their own GI function, starting 2 wk before the study and continuing throughout the study period. Twelve months after the end of the study all patients were asked to complete the same questionnaire regarding their symptomatology as at the start of the study.


All patients tolerated the products well. The patients receiving Lb. plantarum had these bacteria on rectal biopsies. There were no major changes of Enterobacteriaceae in either group, before or after the study, but the Enterococci increased in the placebo group and remained unchanged in the test group. Flatulence was rapidly and significantly reduced in the test group compared with the placebo group (number of days with abundant gas production, test group 6.5 before, 3.1 after vs 7.4 before and 5.6 after for the placebo group). Abdominal pain was reduced in both groups. At the 12-month follow-up, patients in the test group maintained a better overall GI function than control patients. There was no difference between the groups regarding bloating. Fifty-nine percent of the test group patients had a continuous intake of fermented products, whereas the corresponding figure for the control patients was 73%.


The results of the study indicate that the administration of Lb. plantarum with known probiotic properties decreased pain and flatulence in patients with IBS. The fiber content of the test solution was minimal and it is unlikely that the fiber content could have had any effect. This type of probiotic therapy warrants further studies in IBS patients.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    , , , et al. III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101: 927–934.

  2. 2.

    , . Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991;100: 998–1005.

  3. 3.

    . Irritable bowel syndrome: Pathogenesis and management. Lancet 1993;341: 1569–1572.

  4. 4.

    , , . Irritable bowel syndrome. Lancet 1997;350: 1691–1695.

  5. 5.

    , , . Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology 1976;70: 326–330.

  6. 6.

    , , , et al. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983;iii: 589–592.

  7. 7.

    . Role of dietary fiber in irritable bowel syndrome. In: Read NW, ed. Irritable bowel syndrome. Grune & Stratton: London, 1985: 203–222.

  8. 8.

    , , , et al. The fecal microbial population in the irritable bowel syndrome. Microbiology 1982;5: 185–194.

  9. 9.

    , , , et al. The fecal flora of two patients with food-related irritable bowel syndrome during challenge with symptom-provoking foods. J Med Microbiol 1988;26: 295–299.

  10. 10.

    , , . Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998;352: 1187–1189.

  11. 11.

    , , . Genus Clostridium Prazmowski. Sneath PHA, Mair NS, Sharpe ME, Holt JG, eds. Bergey's manual of systematic bacteriology, Vol. 2. Williams & Wilkins: Baltimore, 1980: 1141–1200.

  12. 12.

    . Family I Enterobacteriaceae Rahn. Krieg NR, Holt JG, eds. Bergey's manual of systematic bacteriology, Vol. 1. Williams & Wilkins: Baltimore, 1937: 408–420.

  13. 13.

    . Escherichia Castellani and Chalmers. In: Krieg NR, Holt JG, eds. Bergey's manual of systematic bacteriology, Vol. 1. Williams & Wilkins: Baltimore, 1919: 420–423.

  14. 14.

    , , , et al. Numerical taxonomy of Lactobacillus spp associated to health and diseased mucosa of the human intestines. J Applied Bacteriol 1993;74: 314–323.

  15. 15.

    , , , et al. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol 1998;84: 88–94.

  16. 16.

    , , , et al. Classification of Lactobacillus plantarum by restriction endonuclease analysis of total chromosomal DNA using conventional agarose gel electrophoresis. Int J Syst Bacteriol 1995;45: 670–675.

  17. 17.

    , , , et al. Administration of different Lactobacillus strains in fermented oatmeal soup; in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol 1993;59: 15–20.

  18. 18.

    , , , et al. Randomly amplified polymorphic DNA (RAPD) for rapid typing of Lactobacillus plantarum strains. Lett Appl Microbiol 1995;21: 155–159.

  19. 19.

    . Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 1980;95: 232–241.

  20. 20.

    , . Irritable bowel syndrome: A graduated, multicomponent treatment approach. Ann Intern Med 1992;116: 1009–1016.

  21. 21.

    , , , et al. Survival of Lactobacillus plantarum DSM 9843 and effect on the short chain fatty acid content in faeces after ingestion of ProViva rose-hip drink. Int J Food Microbiol 1998;42: 29–38.

  22. 22.

    , , , et al. Identification of subgroups of functional gastrointestinal disorders. Gastroenterology 1990;3: 159–172.

  23. 23.

    , , . A double-blind crossover study of diphenylhydration in irritable bowel syndrome. J Assoc Physicians India 1983;31: 425–427.

  24. 24.

    , . Treatment of irritable bowel syndrome with lopazepam, hyoscine butylbromide and ispaghula husk. Br Med J 1979;1: 376–378.

Download references


This study was supported by The Swedish Medical Research Council, grant No. K98–17X-11616–03A, the Faculty of Medicine, Lund University, Albert Påhlsson's Foundation, Crafoord's Foundation, and Malmö University Hospital, Sweden.

Author information


  1. Department of Surgery, Lund University, Lund University Hospital, Lund, Sweden

    • Sören Nobaek
  2. Probi AB, Ideon Gamma 1, Lund, Sweden

    • Marie-Louise Johansson
  3. Laboratory of Food Hygiene, Chemical Center, Lund University, Lund, Sweden

    • Göran Molin
    •  & Siv Ahrné
  4. Department of Surgery, Lund University, Malmö University Hospital, Malmö, Sweden

    • Bengt Jeppsson


  1. Search for Sören Nobaek in:

  2. Search for Marie-Louise Johansson in:

  3. Search for Göran Molin in:

  4. Search for Siv Ahrné in:

  5. Search for Bengt Jeppsson in:

Corresponding author

Correspondence to Bengt Jeppsson.

About this article

Publication history






Further reading